The American Kratom Association (AKA) has commended Secretary Kennedy and FDA Commissioner Makary for their recent move to specifically regulate synthetic 7-OH, distinguishing it from the widely used natural kratom plant. In a public statement, the AKA described this as a balanced decision that prioritizes consumer safety while preserving lawful access to natural kratom products.
The association highlighted that synthetic 7-OH is a laboratory-made derivative with far greater risk than kratom in its natural form, which is supported by a longstanding record of responsible use. The AKA praised the federal officials for championing a science-driven approach and underscored the significance for the broader kratom community.
By targeting only synthetic compounds, the new scheduling preserves public access to traditional kratom, which the AKA says benefits countless Americans. For full details, see the official release on Reuters.